Global Women's Health Diagnostics Market 2017-2021

女性医療診断の世界市場2017-2021

◆タイトル:Global Women's Health Diagnostics Market 2017-2021
◆商品コード:IRTNTR13150
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年5月10日
◆ページ数:70
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、女性医療診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、女性医療診断の世界市場規模及び予測、用途別分析、需要先別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

ABSTRACTAbout Women’s Health Diagnostics

Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have led to new product development user-friendly diagnostic instruments for laboratories and physician offices, as well as home-care settings. Manufacturers are increasingly shifting toward shortened analyzer product cycles with value-added features such as portability of instruments to stay ahead in the market.

Technavio’s analysts forecast the global women’s health diagnostics market to grow at a CAGR of 6.58% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global women’s health diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from biomarkers is considered.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Women’s Health Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Laboratories
• F. Hoffmann-La Roche
• Hologic
• Siemens Healthineers

[Other prominent vendors]
• ACON Laboratories
• Alere
• Becton Dickinson (BD)
• bioMérieux
• Bio-Rad Laboratories
• Carl Zeiss Meditec
• Cepheid
• Danaher
• Illumina
• Mindray
• Natera
• Sysmex
• Thermo Fisher Scientific
• Urit Medical

[Market driver]
• Reimbursements for human papillomavirus (HPV) tests.
• For a full, detailed list, view our report

[Market challenge]
• High cost of mammography equipment.
• For a full, detailed list, view our report

[Market trend]
• Increased use of rapid diagnostic testing.
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by application
• Cancer
• UTIs
• Gynecology and fertility
• Osteoporosis

PART 07: Market segmentation by end-user
• Hospitals
• Clinical diagnostic laboratories
• ASCs
• Home-care settings

PART 08: Geographical segmentation
• Women’s health diagnostics market in Americas
• Women’s health diagnostics market in EMEA
• Women’s health diagnostics market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Increased use of rapid diagnostic testing
• Increasing M&As
• Increasing demand for home-care monitoring equipment

PART 12: Vendor landscape
• Competitive scenario

PART 13: Key vendor analysis
• Abbott Laboratories
• F. Hoffmann-La Roche
• Hologic
• Siemens Healthineers
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Global women’s health diagnostics market 2016-2021
Exhibit 02: Global women’s health diagnostics market 2016-2021: Overview
Exhibit 03: Global women’s health diagnostics market 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global women’s health diagnostics market by application, 2016 (%)
Exhibit 06: Global women’s health cancer testing market 2016-2021: Overview
Exhibit 07: Breast cancer: Key takeaways
Exhibit 08: Mammography screening for breast cancer cases (% of women screened)
Exhibit 09: Cervical cancer: Key takeaways
Exhibit 10: Ovarian cancer: Key takeaways
Exhibit 11: Global women’s health cancer testing market 2016-2021 ($ billions)
Exhibit 12: Global women’s health UTI testing market 2016-2021: Overview
Exhibit 13: Global women’s health UTI testing market 2016-2021 ($ billions)
Exhibit 14: UTI testing market: Key takeaways
Exhibit 15: Global women’s health gynecology and fertility testing market 2016-2021: Overview
Exhibit 16: Global women’s health gynecology and fertility testing market 2016-2021 ($ billions)
Exhibit 17: Gynecology and fertility testing market: Key takeaways
Exhibit 18: Global women’s health osteoporosis testing market 2016-2021: Overview
Exhibit 19: Global women’s health osteoporosis testing market 2016-2021 ($ billions)
Exhibit 20: Global women’s health osteoporosis testing market- Key takeaways
Exhibit 21: Global women’s health diagnostics market by end-user (2016)
Exhibit 22: Hospitals in global women’s health diagnostic market
Exhibit 23: Clinical diagnostic laboratories in global women’s health diagnostic market
Exhibit 24: ASCs in global women’s health diagnostic market
Exhibit 25: Home-care settings in global women’s health diagnostics market
Exhibit 26: Buying criteria analysis: Global women’s health diagnostics market by end-users
Exhibit 27: Smoking rate in women aged 15+ year, 2014 (%)
Exhibit 28: Global women’s health diagnostics market by geography 2016 (%)
Exhibit 29: Women’s health diagnostics market in Americas 2016-2021: Overview
Exhibit 30: Women’s health diagnostic market in Americas 2016-2021 ($ billions)
Exhibit 31: Women’s health diagnostics market in EMEA 2016-2021: Overview
Exhibit 32: Women’s health diagnostic market in EMEA 2016-2021 ($ billions)
Exhibit 33: Women’s health diagnostics market in APAC 2016-2021: Overview
Exhibit 34: Women’s health diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 35: Death of women due to breast cancer (%) 2015
Exhibit 36: Survival rate of cervical cancer cases 2013
Exhibit 37: Number of mammography units installed per 1,000,000 inhabitants
Exhibit 38: Advanced catheter portfolio
Exhibit 39: M&As
Exhibit 40: Competitive structure analysis of global women’s health diagnostics market 2016
Exhibit 41: Competitive landscape analysis of global women’s health diagnostics market 2016
Exhibit 42: Strategic success factors of companies in global women’s health diagnostics market
Exhibit 43: Abbott Laboratories: Key highlights
Exhibit 44: Abbott Laboratories: Strength assessment
Exhibit 45: Abbott Laboratories: Strategy assessment
Exhibit 46: Abbott Laboratories: Opportunity assessment
Exhibit 47: F. Hoffmann-La Roche: Key highlights
Exhibit 48: F. Hoffmann-La Roche: Strength assessment
Exhibit 49: F. Hoffmann-La Roche: Strategy assessment
Exhibit 50: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 51: Hologic: Key highlights
Exhibit 52: Hologic: Strategy assessment
Exhibit 53: Hologic: Strategy assessment
Exhibit 54: Hologic: Opportunity assessment
Exhibit 55: Siemens Healthineers: Key highlights
Exhibit 56: Siemens Healthineers: Strength assessment
Exhibit 57: Siemens Healthineers: Strategy assessment
Exhibit 58: Siemens Healthineers: Opportunity assessment
Exhibit 59: Other prominent vendors



【掲載企業】

Abbott Laboratories, F. Hoffmann-La Roche, Hologic, Siemens Healthineers, ACON Laboratories, Alere, Becton DickBulleted List Propertiesinson, bioMérieux, Bio-Rad Laboratories, Carl Zeiss Meditec, Cepheid, Danaher, Illumina, Mindray, Natera, Sysmex, Thermo Fisher Scientific, and Urit Medical.


【資料のキーワード】

女性医療、女性医療健康、女性医療診断、バイオマーカー

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[女性医療診断の世界市場2017-2021] (Global Women's Health Diagnostics Market 2017-2021 / IRTNTR13150)販売に関する免責事項
[女性医療診断の世界市場2017-2021] (Global Women's Health Diagnostics Market 2017-2021 / IRTNTR13150)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆